Discovery of 2-{4-[(3S)-Piperidin-3-yl]phenyl}-2H-indazole-7-carboxamide (MK-4827): A Novel Oral Poly(ADP-ribose)polymerase (PARP) Inhibitor Efficacious in …

…, J Boueres, F Ferrigno, M Fonsi… - Journal of medicinal …, 2009 - ACS Publications
We disclose the development of a novel series of 2-phenyl-2H-indazole-7-carboxamides as
poly(ADP-ribose)polymerase (PARP) 1 and 2 inhibitors. This series was optimized to …

Characterization of the novel positive allosteric modulator of the metabotropic glutamate receptor 4 ADX88178 in rodent models of neuropsychiatric disorders

…, E Le Poul, C Boléa, F Girard, B Campo, M Fonsi… - … of Pharmacology and …, 2014 - ASPET
There is growing evidence that activation of metabotropic glutamate receptor 4 (mGlu 4 )
leads to anxiolytic- and antipsychotic-like efficacy in rodent models, yet its relevance to …

[HTML][HTML] Intra-articular hyaluronic acid and chondroitin sulfate: pharmacokinetic investigation in osteoarthritic rat models

M Fonsi, AI El Amrani, F Gervais, P Vincent - Current Therapeutic Research, 2020 - Elsevier
Background Viscosupplementation of synovial fluid with intra-articular (IA) injections of
hyaluronic acid (HA) is widely used for symptomatic treatment of osteoarthritis (OA). Herein we …

Design and synthesis of bicyclic pyrimidinones as potent and orally bioavailable HIV-1 integrase inhibitors

…, F Fiore, E Monteagudo, M Fonsi… - Journal of medicinal …, 2008 - ACS Publications
HIV integrase is one of the three enzymes encoded by HIV genome and is essential for viral
replication, but integrase inhibitors as marketed drugs have just very recently started to …

Discovery of a potent class I selective ketone histone deacetylase inhibitor with antitumor activity in vivo and optimized pharmacokinetic properties

…, E Monteagudo, M Fonsi… - Journal of medicinal …, 2009 - ACS Publications
The optimization of a potent, class I selective ketone HDAC inhibitor is shown. It possesses
optimized pharmacokinetic properties in preclinical species, has a clean off-target profile, …

High-throughput microsomal stability assay for screening new chemical entities in drug discovery

M Fonsi, MV Orsale, E Monteagudo - SLAS Discovery, 2008 - Elsevier
In this work, the authors present a novel, robotic, automated protocol for assessing a
metabolic stability protocol assembled on a Hamilton platform and a new strategy for pooling …

Identification of MK-5710 ((8aS)-8a-methyl-1, 3-dioxo-2-[(1S, 2R)-2-phenylcyclo-propyl]-N-(1-phenyl-1H-pyrazol-5-yl) hexahydro-imidazo [1, 5-a] pyrazine-7 (1H) …

…, F Colaceci, F Ferrigno, G Filocamo, M Fonsi… - Bioorganic & medicinal …, 2011 - Elsevier
The Hedgehog (Hh-) signaling pathway is a key developmental pathway which gets
reactivated in many human tumors, and smoothened (Smo) antagonists are emerging as novel …

[HTML][HTML] Allometric scaling approaches for predicting human pharmacokinetic of a locked nucleic acid oligonucleotide targeting cancer-associated miR-221

MT Di Martino, M Arbitrio, M Fonsi, CA Erratico… - Cancers, 2019 - mdpi.com
LNA-i-miR-221 is a novel phosphorothioate backbone 13-mer locked nucleic acid
oligonucleotide-targeting microRNA-221 designed for the treatment of human malignancies. To …

N-(2-alkylaminoethyl)-4-(1, 2, 4-oxadiazol-5-yl) piperazine-1-carboxamides as highly potent smoothened antagonists

…, D Branca, G Dessole, A Bresciani, M Fonsi… - Bioorganic & medicinal …, 2011 - Elsevier
Smoothened (Smo) antagonists are emerging as new therapies for the treatment of
neoplasias with aberrantly reactivated hedgehog (Hh) signaling pathway. A novel series of 4-[3-(…

Direct comparison of UDP-glucuronosyltransferase and cytochrome P450 activities in human liver microsomes, plated and suspended primary human hepatocytes …

…, MW den Braver, A Baze, J Decorde, M Fonsi… - European Journal of …, 2017 - Elsevier
UDP-glucuronosyltransferases (UGTs) and cytochrome P450s (CYPs) are the major
enzymes involved in hepatic metabolism of drugs. Hepatic drug metabolism is commonly …